title: Using pharmacogenetics in real time to guide therapy: the warfarin example.
authors.affiliation: The Canadian Pharmacogenomic Network for Drug Safety (CPNDS), Center for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, V5Z4H4, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Aminkeng
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D064417:Vitamin K Epoxide Reductases / Q000235:genetics*; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D001189:Aryl Hydrocarbon Hydroxylases; D064417:Vitamin K Epoxide Reductases